1. Corrigendum to “Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1” [J Hepatol 69 (2018) 1110–1122]

    http://dx.doi.org/10.1016/j.jhep.2018.11.001
  2. Corrigendum to “Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B” [J Hepatol 69 (2018) 278–285]

    http://dx.doi.org/10.1016/j.jhep.2018.12.010
  3. Corrigendum to “Impaired brain glymphatic flow in experimental hepatic encephalopathy” [J Hepatol 69 (2019) 40–49]

    http://dx.doi.org/10.1016/j.jhep.2018.12.012
  4. Corrigendum to “EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma” [J Hepatol 69 (2018) 182–236]

    http://dx.doi.org/10.1016/j.jhep.2019.01.020
  5. Mortality of acute-on-chronic liver failure: What is the role of obesity?

    http://dx.doi.org/10.1016/j.jhep.2019.01.018
  6. Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome

    http://dx.doi.org/10.1016/j.jhep.2019.01.009
  7. Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion molecules

    http://dx.doi.org/10.1016/j.jhep.2019.01.019
  8. NAFLD and beneficial effects of lifestyle intervention: Defining the meat of the matter

    http://dx.doi.org/10.1016/j.jhep.2019.01.024
  9. Clinical utility of genomic analysis in adults with idiopathic liver disease

    http://dx.doi.org/10.1016/j.jhep.2019.01.036
  10. Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

    http://dx.doi.org/10.1016/j.jhep.2019.02.006
Copyright © 2015 0168-8278的搜索结果由GYCC学术搜索提供 - 意见反馈 >>小额捐赠|打赏